Desirable Biological Variation Database specifications
The 2014 edition of Desirable Specifications for imprecision, inaccuracy, and total allowable error, calculated from data on within-subject and between-subject biologic variation. This database was updated and compiled by Dr. Carmen Ricos and colleagues, before the EFLM took the helm. As of May 2019, EFLM is managing the new biological variation database. We were honored to host this database for 15 years.
Desirable Specifications for Total Error, Imprecision, and Bias, derived from intra- and inter-individual biologic variation
This most recent and extensive listing of biologic goals has been provided by Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M. "Current databases on biologic variation: pros, cons and progress." Scand J Clin Lab Invest 1999;59:491-500. This database was last updated in 2014.
Annex I, Part I: Within-subject and between-subject CV values of analytes and Desirable Analytical Quality Specifications for imprecision, bias and total error
See The Reference List
See The References
See The original Guest Essay
Note on abbreviations:
CVI = within-subject biologic variation
CVG = between-subject biologic variation
I = desirable specification for imprecision
B = desirable specification for inaccuracy
TE = desirable specification for allowable total error
|
Analyte |
Number of Papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
S- |
11-Desoxycortisol |
2 |
21.3 |
31.5 |
10.7 |
9.5 |
27.1 |
S- |
17-Hydroxyprogesterone |
2 |
19.6 |
50.4 |
9.8 |
13.5 |
29.7 |
U- |
4-hydroxy-3-methoximandelate (VMA) |
1 |
22.2 |
47.0 |
11.1 |
13.0 |
31.3 |
S- |
5' Nucleotidase |
2 |
23.2 |
19.9 |
11.6 |
7.6 |
26.8 |
U- |
5'-Hydroxyindolacetate, concentration |
1 |
20.3 |
33.2 |
10.2 |
9.7 |
26.5 |
S- |
α1-Acid Glycoprotein |
3 |
11.3 |
24.9 |
5.7 |
6.8 |
16.2 |
S- |
α1-Antichymotrypsin |
1 |
13.5 |
18.3 |
6.8 |
5.7 |
16.8 |
S- |
α1-Antitrypsin |
3 |
5.9 |
16.3 |
3.0 |
4.3 |
9.2 |
S- |
α1-Globulins |
2 |
11.4 |
22.6 |
5.7 |
6.3 |
15.7 |
U- |
α1-Microglobulin, concentration, first morning |
1 |
33.0 |
58.0 |
16.5 |
16.7 |
43.9 |
P- |
α2-Antiplasmin |
1 |
6.2 |
--- |
3.1 |
--- |
--- |
S- |
α2-Globulins |
2 |
10.3 |
12.7 |
5.2 |
4.1 |
12.6 |
S- |
α2-Macroglobulin |
4 |
3.4 |
18.7 |
1.7 |
4.75 |
7.56 |
U- |
α2-Microglobulin output, first morning |
1 |
29.0 |
32.0 |
14.5 |
10.8 |
34.7 |
P- |
α-aminobutryic acid |
1 |
24.7 |
32.3 |
12.4 |
10.2 |
30.5 |
S- |
α-Amylase |
7 |
8.7 |
28.3 |
4.4 |
7.4 |
14.6 |
S- |
α-Amylase (pancreatic) |
2 |
11.7 |
29.9 |
5.9 |
8.0 |
17.7 |
U- |
α-Amylase (pancreatic) |
2 |
69.5 |
105.0 |
34.75 |
31.48 |
88.82 |
U- |
α-Amylase concentration, random |
1 |
94.0 |
46.0 |
47.0 |
26.2 |
103.7 |
P- |
α-Carotene |
1 |
24.0 |
65.0 |
12.0 |
17.3 |
37.1 |
S- |
α-Carotene |
1 |
48.0 |
65.0 |
24.0 |
20.2 |
59.8 |
S- |
α-Fetoprotein(non hepatic carcinoma) |
2 |
12.2 |
45.6 |
6.1 |
11.8 |
21.9 |
S- |
α-Tocopherol |
3 |
13.8 |
15.0 |
6.9 |
5.1 |
16.5 |
S- |
Acid phosphatase |
2 |
8.9 |
8.0 |
4.5 |
3.0 |
10.3 |
S- |
Acid phosphatase tartrate-resistant (TR-ACP) |
2 |
8.0 |
13.3 |
4.0 |
3.9 |
10.5 |
S- |
Acid phosphatase prostatic activity (PAP) |
1 |
33.8 |
--- |
16.9 |
--- |
--- |
P- |
Activated partial thromboplastine time |
3 |
2.7 |
8.6 |
1.4 |
2.3 |
4.5 |
P- |
Adiponectin |
1 |
18.8 |
51.2 |
9.4 |
13.6 |
29.1 |
S- |
Adenosine deaminase (ADA) |
1 |
11.7 |
25.5 |
5.9 |
7.0 |
16.7 |
P- |
Alanine |
1 |
14.7 |
55.8 |
7.4 |
14.4 |
26.6 |
S- |
Alanine aminopeptidase |
1 |
4.1 |
--- |
2.1 |
--- |
--- |
S- |
Alanine aminotransferase (ALT) |
9 |
19.40 |
41.6 |
9.7 |
11.48 |
27.48 |
Back to top
|
Analyte |
Number of papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
S- |
Albumin |
24 |
3.2 |
4.75 |
1.6 |
1.43 |
4.07 |
U- |
Albumin, concentration, first morning |
3 |
36.0 |
55.0 |
18.0 |
16.4 |
46.1 |
U- |
Albumin, output, night urine |
3 |
29.5 |
58.0 |
14.8 |
16.3 |
40.6 |
S- |
Albumin, glycated |
1 |
5.2 |
10.3 |
2.6 |
2.9 |
7.2 |
S- |
Aldosterone |
2 |
29.4 |
40.1 |
14.7 |
12.4 |
36.7 |
U- |
Aldosterone |
1 |
39.4 |
40.1 |
19.7 |
14.05 |
46.56 |
S- |
Alkaline phosphatase |
22 |
6.45 |
26.1 |
3.23 |
6.72 |
12.04 |
S- |
Alkaline phosphatase, bone |
4 |
6.2 |
37.4 |
3.1 |
9.5 |
14.6 |
S- |
Alkaline phosphatase, liver |
1 |
10.0 |
27.0 |
5.0 |
7.2 |
15.4 |
S- |
Alkaline phosphatase, placental |
1 |
19.1 |
--- |
9.6 |
--- |
--- |
U- |
Ammonia, output, 24h |
1 |
24.7 |
27.3 |
12.4 |
9.2 |
29.6 |
S- |
Amyloid A |
1 |
25.0 |
61.0 |
12.5 |
16.5 |
37.1 |
S- |
Androstendione |
2 |
15.8 |
38.8 |
7.9 |
10.47 |
23.51 |
S- |
Anion gap |
|
9.5 |
10.1 |
4.8 |
3.5 |
11.3 |
P- |
Antithrombin III |
4 |
5.2 |
15.3 |
2.6 |
4.0 |
8.3 |
S- |
Apolipoprotein A1 |
11 |
6.5 |
13.4 |
3.3 |
3.7 |
9.1 |
S- |
Apolipoprotein B |
9 |
6.9 |
22.8 |
3.5 |
6.0 |
11.6 |
P- |
Arginine |
1 |
19.3 |
34.1 |
9.7 |
9.8 |
25.7 |
S- |
Arilestearase activity, non inhibited |
1 |
3.8 |
37.2 |
1.9 |
9.3 |
12.5 |
P- |
Ascorbate (Vitamin C) |
1 |
20.0 |
21.0 |
10.0 |
7.3 |
23.8 |
S- |
Ascorbate (Vitamin C) |
3 |
26.0 |
31.0 |
13.0 |
10.1 |
31.6 |
P- |
Asparagine |
1 |
12.3 |
28.0 |
6.2 |
7.6 |
17.8 |
S- |
Aspartate aminotransferase (AST) |
13 |
12.3 |
23.1 |
6.15 |
6.54 |
16.69 |
P- |
Aspartic acid |
1 |
31.2 |
55.1 |
15.6 |
15.8 |
41.6 |
S- |
β-2-Microglobulin |
1 |
5.9 |
15.5 |
3.0 |
4.1 |
9.0 |
P- |
β-Carotene |
1 |
18.0 |
48.0 |
9.0 |
12.8 |
27.7 |
S- |
β-Carotene |
4 |
36.0 |
39.7 |
18.0 |
13.4 |
43.1 |
S- |
β-Cryptoxantin |
1 |
36.7 |
--- |
18.4 |
--- |
--- |
S- |
β-Globulins |
2 |
10.1 |
9.1 |
5.1 |
3.4 |
11.7 |
B- |
Base excess |
1 |
76.4 |
43.2 |
38.2 |
21.9 |
85.0 |
B- |
Basophile, count |
3 |
28.0 |
54.8 |
14.0 |
15.4 |
38.5 |
S- |
Bilirubin total |
11 |
21.8 |
28.4 |
10.90 |
8.95 |
26.94 |
S- |
Bilirubin conjugated |
2 |
36.8 |
43.2 |
18.4 |
14.2 |
44.5 |
P- |
C Protein |
1 |
5.6 |
55.2 |
2.9 |
13.9 |
18.7 |
S- |
C reactive protein |
3 |
42.2 |
76.3 |
21.1 |
21.8 |
56.6 |
S- |
C reactive protein - high sensitivity |
1 |
49.70 |
89.23 |
24.85 |
25.53 |
66.54 |
S- |
C3 Complement |
2 |
5.2 |
15.6 |
2.6 |
4.1 |
8.4 |
S- |
C4 Complement |
2 |
8.9 |
33.4 |
4.5 |
8.6 |
16.0 |
S- |
CA 125 antigen |
4 |
24.7 |
54.6 |
12.4 |
15.0 |
35.4 |
S- |
CA 15.3 antigen |
5 |
6.1 |
62.9 |
3.1 |
15.8 |
20.8 |
S- |
CA 19.9 antigen |
2 |
16.0 |
130.5 |
7.98 |
32.87 |
46.03 |
S- |
CA 549 antigen |
1 |
9.1 |
33.4 |
4.6 |
8.7 |
16.2 |
Back to top
|
Analyte |
Number of papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
S- |
Calcium |
24 |
2.1 |
2.5 |
1.05 |
0.82 |
2.55 |
S- |
Calcium, complexed |
1 |
5.3 |
4.5 |
2.7 |
1.7 |
6.1 |
U- |
Calcium, concentration, 24h |
4 |
27.5 |
36.6 |
13.8 |
11.4 |
34.1 |
S- |
Calcium, ionized |
2 |
1.7 |
1.9 |
0.9 |
0.6 |
2.0 |
S- |
Calcium, protein bound |
1 |
4.1 |
6.1 |
2.1 |
1.8 |
5.2 |
S- |
Calcium, ultrafiltrable |
1 |
2.2 |
2.7 |
1.1 |
0.9 |
2.7 |
S- |
Carbohydrate deficient transferrin |
1 |
7.1 |
38.7 |
3.6 |
9.8 |
15.7 |
B- |
CO2, total |
1 |
4.0 |
4.8 |
2.0 |
1.56 |
4.86 |
S- |
Carcinoembryonic antigen (CEA) |
10 |
12.7 |
55.6 |
6.4 |
14.3 |
24.7 |
S- |
Carnitine, Acyl-free |
1 |
11.35 |
24.3 |
5.68 |
6.71 |
16.07 |
S- |
Carnitine, free |
1 |
8.05 |
16.65 |
4.03 |
4.62 |
11.26 |
S- |
Carnitine, total |
1 |
8.85 |
11.80 |
4.43 |
3.69 |
10.99 |
S- |
Ceruloplasmin (ferroxidase) |
2 |
5.8 |
11.1 |
2.9 |
3.1 |
7.9 |
S- |
Chloride |
19 |
1.2 |
1.5 |
0.6 |
0.5 |
1.5 |
S- |
Cholesterol |
46 |
5.95 |
15.3 |
2.98 |
4.1 |
9.01 |
S- |
Cholinesterase, concentration |
2 |
7.1 |
--- |
3.6 |
--- |
--- |
S- |
Cholinesterase, activity |
3 |
6.1 |
18.2 |
3.1 |
4.8 |
9.8 |
P- |
Chromogranin A |
1 |
12.8 |
26.3 |
6.4 |
7.3 |
17.9 |
P- |
Citrulline |
1 |
21.4 |
43.9 |
10.7 |
12.2 |
29.9 |
S- |
Collagen type I C propeptide (PICP) |
3 |
7.8 |
26.7 |
3.9 |
7.0 |
13.4 |
S- |
Collagen type I N propeptide (PINP) |
3 |
7.4 |
57.3 |
3.7 |
14.4 |
20.5 |
S- |
Collagen type III N propeptide (PIIINP) |
1 |
13.6 |
87.2 |
6.8 |
22.1 |
33.3 |
U- |
Color, first morning |
1 |
30.9 |
47.4 |
15.5 |
14.1 |
39.6 |
P- |
Copper |
3 |
8.0 |
19.0 |
4.0 |
5.2 |
11.8 |
S- |
Copper |
2 |
4.7 |
13.6 |
2.35 |
3.6 |
7.47 |
P- |
Cortisol |
1 |
21.7 |
46.2 |
10.85 |
12.76 |
30.66 |
S- |
Cortisol |
3 |
15.2 |
38.1 |
7.6 |
10.26 |
22.8 |
S- |
C Peptide |
3 |
16.6 |
23.2 |
8.3 |
7.1 |
20.8 |
S- |
Creatine kinase (CK) |
9 |
22.8 |
40.0 |
11.4 |
11.5 |
30.3 |
S- |
Creatine kinase MB, % |
1 |
6.9 |
48.2 |
3.5 |
10.8 |
16.5 |
S- |
Creatine kinase MB, activity |
4 |
19.7 |
24.3 |
9.9 |
7.8 |
24.1 |
S- |
Creatine kinase MB, mass |
1 |
18.4 |
61.2 |
9.2 |
14.88 |
30.06 |
S- |
Creatinine |
28 |
5.95 |
14.7 |
2.98 |
3.96 |
8.87 |
U- |
Creatinine, concentration, 24h |
8 |
24.0 |
24.5 |
12.0 |
8.6 |
28.4 |
U- |
Creatinine, concentration, first morning |
8 |
23.2 |
25.7 |
11.6 |
8.7 |
27.8 |
U- |
Creatinine, concentration, random |
8 |
36.3 |
32.4 |
18.2 |
12.2 |
42.1 |
U- |
Creatinine, output, 24h |
8 |
11.0 |
23.0 |
5.5 |
6.4 |
15.4 |
S- |
C-Terminal telopeptide type I collagen (CTY I) |
5 |
10.85 |
30.6 |
5.43 |
8.12 |
15.45 |
S- |
Cyfra 21.1 Antigen |
2 |
22.2 |
31.1 |
11.1 |
9.6 |
27.9 |
P- |
Cystatin C |
1 |
5.5 |
--- |
2.8 |
--- |
--- |
S- |
Cystatin C |
4 |
5.0 |
13.0 |
2.5 |
3.48 |
7.61 |
P- |
Cysteine |
1 |
5.9 |
12.3 |
3.0 |
3.4 |
8.3 |
P- |
Cystine |
1 |
38.3 |
48.5 |
19.2 |
15.4 |
47.0 |
Back to top
|
Analyte |
Number of Papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
S- |
D-Dimer (MoM) |
1 |
23.3 |
26.5 |
11.65 |
8.82 |
28.04 |
S- |
Dehydroepiandrosterone sulfate (DHEAS) |
3 |
6.35 |
30.70 |
3.188 |
7.84 |
13.08 |
U- |
Deoxypyridinoline/creatinine, 24h |
2 |
16.0 |
30.7 |
8.0 |
8.7 |
21.9 |
U- |
Deoxypyridinoline/creatinine, first morning |
2 |
13.8 |
34.6 |
6.9 |
9.3 |
20.7 |
U- |
Deoxipyridinoline/minute, first morning |
2 |
15.4 |
30.3 |
7.7 |
8.5 |
21.2 |
P- |
Dipeptidyl-peptidase IV (ACE) |
2 |
8.2 |
14.5 |
4.1 |
4.2 |
10.9 |
S- |
Dipeptidyl-peptidase IV (ACE) |
1 |
12.5 |
27.7 |
6.3 |
7.6 |
17.9 |
P- |
Elastase |
1 |
12.4 |
15.1 |
6.2 |
4.88 |
15.11 |
B- |
Eosinophils, count |
3 |
21.0 |
76.4 |
10.5 |
19.8 |
37.1 |
(B)Plat- |
Epinephrine |
1 |
25.3 |
--- |
12.7 |
--- |
--- |
P- |
Epinephrine |
1 |
48.3 |
--- |
24.2 |
--- |
--- |
B- |
Erythrocytes, count |
7 |
3.2 |
6.3 |
1.6 |
1.7 |
4.4 |
B- |
Erythrocyte distribution wide |
|
3.5 |
5.7 |
1.8 |
1.7 |
4.6 |
U- |
Estradiol |
1 |
30.4 |
--- |
15.2 |
--- |
--- |
S- |
Estradiol |
5 |
22.5 |
24.4 |
11.25 |
8.3 |
26.86 |
S- |
Estradiol, free |
1 |
22.8 |
--- |
11.40 |
--- |
--- |
U- |
Estradiol, free |
1 |
38.6 |
--- |
19.3 |
--- |
--- |
P- |
Factor V coagulation |
1 |
3.6 |
--- |
1.8 |
--- |
--- |
P- |
Factor VII coagulation |
2 |
6.8 |
19.4 |
3.4 |
5.1 |
10.7 |
P- |
Factor VIII coagulation |
2 |
4.8 |
19.1 |
2.4 |
4.9 |
8.9 |
P- |
Factor X coagulation |
1 |
5.9 |
--- |
3.0 |
--- |
--- |
S- |
Ferritin |
6 |
14.2 |
15.0 |
7.1 |
5.2 |
16.9 |
P- |
Fibrinogen |
5 |
10.7 |
15.8 |
5.4 |
4.8 |
13.6 |
(B)Erthry- |
Folate |
1 |
12.0 |
66.0 |
6.0 |
16.8 |
26.7 |
S- |
Folate |
1 |
24.0 |
73.0 |
12.0 |
19.2 |
39.0 |
S- |
Follicle stimulating hormone (FSH) |
5 |
11.0 |
47.2 |
5.5 |
12.12 |
21.19 |
S- |
Fructosamine |
3 |
3.4 |
5.9 |
1.7 |
1.7 |
4.5 |
S- |
Galactosyl hydroxylysine |
1 |
11.8 |
25.8 |
5.9 |
7.1 |
16.8 |
P- |
γ-Fibrinogen |
1 |
14.1 |
27.25 |
7.05 |
7.67 |
19.3 |
S- |
γ-Globulins |
2 |
14.6 |
12.3 |
7.3 |
4.8 |
16.8 |
S- |
γ-glutamyltransferase (GGT) |
10 |
13.4 |
42.15 |
6.7 |
11.06 |
22.11 |
S- |
Globulins, total |
1 |
5.5 |
12.9 |
2.8 |
3.5 |
8.0 |
P- |
Glucose |
1 |
4.5 |
5.8 |
2.3 |
1.8 |
5.5 |
S- |
Glucose |
15 |
5.6 |
7.5 |
2.8 |
2.34 |
6.96 |
(B)Erythr- |
Glucose-6-phosphate-1-dehydrogenase (G6PDH) |
1 |
32.8 |
31.8 |
16.4 |
11.4 |
38.5 |
B - spot |
Glucose-6-phosphate-1-dehydrogenase (G6PDH) |
1 |
7.3 |
10.3 |
3.7 |
3.2 |
9.2 |
P- |
Glutamic acid |
1 |
46.4 |
79.9 |
23.2 |
23.1 |
61.4 |
P- |
Glutamine |
1 |
12.1 |
22.0 |
6.1 |
6.3 |
16.3 |
S- |
Glutathion peroxidase |
1 |
7.2 |
21.7 |
3.6 |
5.7 |
11.7 |
P- |
Glycine |
1 |
11.8 |
40.3 |
5.9 |
10.5 |
20.2 |
P- |
Haptoglobin |
1 |
20.0 |
27.9 |
10.0 |
8.6 |
25.1 |
S- |
Haptoglobin |
3 |
20.4 |
36.4 |
10.2 |
10.4 |
27.3 |
S- |
HDL cholesterol |
25 |
7.3 |
21.2 |
3.65 |
5.61 |
11.63 |
S- |
HDL 1 cholesterol |
1 |
5.5 |
27.2 |
2.8 |
6.9 |
11.5 |
S- |
HDL 2 cholesterol |
6 |
15.7 |
40.7 |
7.9 |
10.9 |
23.9 |
S- |
HDL 3 cholesterol |
6 |
7.0 |
14.3 |
3.5 |
4.0 |
9.8 |
B- |
Hematocrit |
11 |
2.7 |
6.41 |
1.35 |
1.74 |
3.97 |
B- |
Hemoglobin |
13 |
2.85 |
6.8 |
1.43 |
1.84 |
4.19 |
B- |
Hemoglobin A1 C |
8 |
1.9 |
5.7 |
0.9 |
1.5 |
3.0 |
B- |
Hemoglobin A2 |
1 |
0.7 |
7.7 |
0.35 |
1.93 |
2.51 |
P- |
Histidine |
1 |
9.7 |
27.2 |
4.9 |
7.2 |
15.2 |
P- |
Homocysteine |
3 |
8.3 |
33.5 |
4.15 |
8.63 |
15.48 |
S- |
Hyaluronic acid |
1 |
62.00 |
--- |
31.00 |
--- |
--- |
S- |
Hydroxybutyrate dehydrogenase |
1 |
6.6 |
--- |
3.3 |
--- |
--- |
P- |
Hydroxyproline |
1 |
34.5 |
56.7 |
17.3 |
16.6 |
45.1 |
U- |
Hydroxyproline/minute, first morning |
1 |
36.1 |
38.8 |
18.1 |
13.2 |
43.0 |
U- |
Hydroxyproline/minute, second void |
1 |
40.5 |
32.9 |
20.3 |
13.0 |
46.5 |
Back to top
|
Analyte |
Number of papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
S- |
Immunoglobulin A |
7 |
5.4 |
35.9 |
2.7 |
9.1 |
13.5 |
S- |
Immunoglobulin G |
6 |
4.5 |
16.5 |
2.3 |
4.3 |
8.0 |
S- |
Immunoglobulin M |
5 |
5.9 |
47.3 |
3.0 |
11.9 |
16.8 |
S- |
Immunoglobulins κ chains |
3 |
4.8 |
15.3 |
2.4 |
4.0 |
8.0 |
S- |
Immunoglobulins λ chains |
3 |
4.8 |
18.0 |
2.4 |
4.7 |
8.6 |
S- |
Inhibin B |
1 |
10.0 |
25.0 |
5 |
6.73 |
14.98 |
S- |
Insulin |
4 |
21.1 |
58.3 |
10.6 |
15.5 |
32.9 |
S- |
Insulin-like growth factor (IGF-1) |
2 |
14.6 |
45.4 |
7.3 |
11.9 |
24.0 |
S- |
Insulin-like growth factor binding protein 3 (IGFBP-3) |
1 |
10.1 |
63.9 |
5.1 |
16.2 |
24.5 |
S- |
Intercellular adhesion molecule-1 (ICAM-1) |
1 |
1.9 |
21.0 |
1.0 |
5.3 |
6.8 |
(B)Leuc- |
Interferon receptor |
1 |
14.0 |
20.0 |
7.0 |
6.1 |
17.7 |
S- |
Interleukin 1-β |
1 |
30.0 |
36.0 |
15.0 |
11.7 |
36.5 |
S- |
Interleukin-8 |
1 |
24.0 |
31.0 |
12.0 |
9.8 |
29.6 |
S- |
Iron |
11 |
26.5 |
23.2 |
13.3 |
8.8 |
30.7 |
P- |
Isoleucine |
1 |
15.5 |
45.5 |
7.8 |
12.0 |
24.8 |
S- |
Kallicrein 6 |
1 |
11.80 |
27.6 |
5.9 |
7.5 |
17.24 |
B- |
Lactate |
1 |
27.2 |
16.7 |
13.6 |
8.0 |
30.4 |
S- |
Lactate dehydrogenase (LDH) |
11 |
8.6 |
14.7 |
4.3 |
4.3 |
11.4 |
S- |
Lactate dehydrogenase 1 isoform (LDH1) |
2 |
2.3 |
8.3 |
1.2 |
2.2 |
4.1 |
S- |
Lactate dehydrogenase 2 isoform (LDH2) |
1 |
3.3 |
2.4 |
1.7 |
1.0 |
3.7 |
S- |
Lactate dehydrogenase 3 isoform (LDH3) |
1 |
2.8 |
3.8 |
1.4 |
1.2 |
3.5 |
S- |
Lactate dehydrogenase 4 isoform (LDH4) |
1 |
5.9 |
5.3 |
3.0 |
2.0 |
6.9 |
S- |
Lactate dehydrogenase 5 isoform (LDH5) |
1 |
8.0 |
9.6 |
4.0 |
3.1 |
9.7 |
P- |
Lactoferrin |
1 |
11.8 |
23.7 |
5.9 |
6.6 |
16.4 |
S- |
LDL Cholesterol |
6 |
7.8 |
20.4 |
3.9 |
5.46 |
11.9 |
P- |
LDL Cholesterol (oxidized) |
1 |
21.0 |
50.0 |
10.5 |
13.6 |
30.9 |
S- |
LDL Cholesterol, small dense |
1 |
9.1 |
20.0 |
4.55 |
5.49 |
13.0 |
S- |
LDL receptor mRNA |
1 |
21.5 |
13.6 |
10.8 |
6.4 |
24.1 |
P- |
Leucine |
1 |
14.8 |
44.0 |
7.4 |
11.6 |
23.8 |
B- |
Leukocytes count |
8 |
11.4 |
21.3 |
5.73 |
6.05 |
15.49 |
S- |
Lipase |
3 |
32.2 |
31.8 |
16.1 |
11.31 |
37.88 |
S- |
Lipoprotein (a) |
3 |
20.8 |
18.1 |
10.4 |
6.9 |
24.1 |
P- |
Lutein |
1 |
13.0 |
21.0 |
6.5 |
6.2 |
16.9 |
S- |
Lutein |
1 |
23.7 |
--- |
11.9 |
--- |
--- |
S- |
Luteinizing hormone (LH) |
5 |
23.0 |
27.4 |
11.5 |
8.94 |
27.92 |
P- |
Lycopene |
1 |
22.0 |
33.0 |
11.0 |
9.9 |
28.1 |
S- |
Lycopene |
2 |
40.1 |
33.0 |
20.1 |
13.0 |
--- |
B- |
Lymphocytes, count |
1 |
10.2 |
35.3 |
5.1 |
9.19 |
17.6 |
B- |
Lymphocytes CD4 |
5 |
25.0 |
--- |
12.5 |
--- |
--- |
P- |
Lysine |
1 |
11.5 |
38.2 |
5.8 |
10.0 |
19.5 |
Back to top
|
Analyte |
Number of Papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
(B)Erythr- |
Magnesium |
2 |
5.6 |
11.3 |
2.8 |
3.2 |
7.8 |
(B)Leuc- |
Magnesium |
1 |
18.5 |
12.4 |
9.25 |
5.57 |
20.83 |
(B)Mon - |
Magnesium |
1 |
18.1 |
20.3 |
9.1 |
6.8 |
21.7 |
S- |
Magnesium |
9 |
3.6 |
6.4 |
1.8 |
1.8 |
4.8 |
U- |
Magnesium, ionized |
1 |
1.9 |
5.1 |
1.0 |
1.4 |
2.9 |
U- |
Magnesium, output, 24h |
2 |
38.3 |
37.6 |
19.2 |
13.4 |
45.0 |
(B)Erythr- |
Mean corpuscular hemoglobin (MCH) |
4 |
1.4 |
5.2 |
0.7 |
1.35 |
2.5 |
(B)Erythr- |
Mean corpuscular hemoglobin concentration (MCHC) |
5 |
1.06 |
1.2 |
0.53 |
0.4 |
1.27 |
(B)Erythr- |
Mean corpuscular volume (MCV) |
7 |
1.4 |
4.85 |
0.7 |
1.26 |
2.42 |
(B)Plat- |
Mean platelet volume (MPV) |
3 |
4.3 |
8.1 |
2.15 |
2.29 |
5.84 |
P- |
Metionine |
1 |
14.7 |
43.4 |
7.4 |
11.5 |
23.6 |
B- |
Monocytes, count |
3 |
17.8 |
49.8 |
8.9 |
13.2 |
27.9 |
S- |
Myeloperoxidase |
1 |
36.0 |
30.0 |
18.0 |
11.7 |
41.4 |
S- |
Myoglobin |
2 |
13.9 |
29.6 |
7.0 |
8.2 |
19.6 |
U- |
N-Acetyl Glucosaminidase, concentration, first morning |
2 |
52.9 |
22.0 |
26.5 |
14.3 |
58.0 |
U- |
N-Acetyl Glucosaminidase/Creatinine |
2 |
51.1 |
21.8 |
25.6 |
13.9 |
56.0 |
B- |
Neutrophyles, count |
5 |
17.1 |
32.8 |
8.55 |
9.25 |
23.35 |
U- |
Nitrogen, output |
1 |
13.9 |
24.2 |
7.0 |
7.0 |
18.4 |
B(Plat)- |
Norepinephrine |
1 |
9.5 |
--- |
4.8 |
--- |
--- |
P- |
Norepinephrine |
1 |
19.5 |
--- |
9.8 |
--- |
--- |
U- |
N-Telopeptide type I collagen |
3 |
15.5 |
37.6 |
7.75 |
10.17 |
22.95 |
S- |
N-terminal (NT)-proBNP |
2 |
10.0 |
16.0 |
5.0 |
4.7 |
13.0 |
P- |
Ornithine |
1 |
18.4 |
54.9 |
9.2 |
14.5 |
29.7 |
P- |
Osmolality |
1 |
1.3 |
1.5 |
0.7 |
0.5 |
1.6 |
Saliva- |
Osmolality |
1 |
9.5 |
35.8 |
4.8 |
9.3 |
17.1 |
S- |
Osmolality |
1 |
1.3 |
1.2 |
0.7 |
0.4 |
1.5 |
U- |
Osmolality, first morning |
1 |
28.3 |
57.9 |
14.2 |
16.1 |
39.5 |
S- |
Osteocalcin |
5 |
6.35 |
30.9 |
3.18 |
7.89 |
13.13 |
U- |
Oxalate, concentration, 24h |
1 |
44.0 |
18.0 |
22.0 |
11.9 |
48.2 |
U- |
Oxalate, output, 24h |
1 |
42.5 |
19.9 |
21.3 |
11.7 |
46.8 |
Back to top
|
Analyte
|
Number of papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
B- |
pCO2 |
1 |
4.8 |
5.3 |
2.4 |
1.8 |
5.7 |
B- |
pH [H+] |
1 |
3.5 |
2.0 |
1.8 |
1.0 |
3.9 |
B- |
pH (pH units) |
1 |
0.2 |
--- |
0.1 |
--- |
--- |
S- |
Paraoxonase 1 |
1 |
13.4 |
84.0 |
6.7 |
21.3 |
32.3 |
S- |
Paraoxonase 1 substrate inhibition (PON 4SI) |
1 |
3.9 |
80.1 |
1.9 |
20.0 |
23.2 |
S- |
Paraoxonase, activity (salt stimulated) |
1 |
8.0 |
86.4 |
4.0 |
21.7 |
28.3 |
P- |
Parathyroid hormone (PTH) |
1 |
25.3 |
43.4 |
12.65 |
12.56 |
33.43 |
S- |
Parathyroid hormone (PTH) |
1 |
25.9 |
23.8 |
13.0 |
8.8 |
30.2 |
S- |
Phenylacetate |
1 |
6.6 |
25.2 |
3.3 |
6.5 |
12.0 |
P- |
Phenylalanine |
1 |
9.5 |
40.6 |
4.8 |
10.4 |
18.3 |
S- |
Phosphate |
17 |
8.15 |
10.8 |
4.08 |
3.38 |
10.11 |
U- |
Phosphate, output, 24h |
5 |
18.0 |
22.6 |
9.0 |
7.2 |
22.1 |
Patient- |
Phosphate tubular reabsorption |
1 |
2.7 |
3.3 |
1.4 |
1.1 |
3.3 |
S- |
Phospholipids |
1 |
6.5 |
11.1 |
3.3 |
3.2 |
8.6 |
P- |
Plasminogen |
1 |
7.7 |
--- |
3.9 |
--- |
--- |
B- |
Platelets, count |
7 |
9.1 |
21.9 |
4.6 |
5.9 |
13.4 |
B- |
Platelet distribution wide |
2 |
2.8 |
--- |
1.4 |
--- |
--- |
B- |
Plateletcrit |
2 |
11.9 |
--- |
6.0 |
--- |
--- |
U- |
Porphobilinogen |
1 |
17.0 |
31.0 |
8.5 |
8.8 |
22.9 |
U- |
Porphyrins (total) |
1 |
40.0 |
--- |
20.0 |
--- |
--- |
(B)Leuc- |
Potassium |
1 |
13.6 |
13.4 |
6.8 |
4.8 |
16.0 |
S- |
Potassium |
20 |
4.6 |
5.6 |
2.3 |
1.81 |
5.61 |
U- |
Potassium, output |
4 |
24.4 |
22.2 |
12.2 |
8.2 |
28.4 |
S- |
Prealbumin |
1 |
10.9 |
19.1 |
5.5 |
5.5 |
14.5 |
S- |
Pregnancy-associated plasma protein A (PAPP-A) |
1 |
12.6 |
14.0 |
6.3 |
4.71 |
15.1 |
P- |
Prolactin |
1 |
39.2 |
65.1 |
19.6 |
19.0 |
51.34 |
S- |
Prolactin |
4 |
23.0 |
35.0 |
11.5 |
10.5 |
29.4 |
P- |
Proline |
1 |
17.0 |
104.4 |
8.5 |
26.4 |
40.5 |
P- |
Prolyl endopeptidase |
2 |
16.8 |
13.9 |
8.4 |
5.5 |
19.3 |
S- |
Properdin factor B |
1 |
9.5 |
11.2 |
4.7 |
3.7 |
11.5 |
S- |
Prostatic specific antigen (PSA) |
3 |
18.1 |
72.4 |
9.1 |
18.7 |
33.6 |
S- |
Protein |
18 |
2.75 |
4.7 |
1.38 |
1.36 |
3.63 |
S- |
Protein, glycated |
1 |
0.9 |
11.6 |
0.5 |
2.9 |
3.7 |
U- |
Protein, output, 24h |
2 |
35.5 |
23.7 |
17.8 |
10.7 |
40.0 |
P- |
Prothrombin time |
2 |
4.0 |
6.8 |
2.0 |
2.0 |
5.3 |
U- |
Pyridinoline |
1 |
19.4 |
23.6 |
9.7 |
7.6 |
23.6 |
B- |
Pyruvate |
1 |
15.2 |
13.0 |
7.6 |
5.0 |
17.5 |
S- |
Receptor for advanced glycation end-products (RAGE) |
1 |
14.6 |
56.5 |
7.3 |
14.59 |
26.63 |
B- |
Red cell distribution wide (RDW) |
4 |
3.5 |
5.7 |
1.8 |
1.7 |
4.6 |
B- |
Reticulocyte highly fluorescent, count |
1 |
10.0 |
62.0 |
5.0 |
15.7 |
24.0 |
B- |
Reticulocyte low fluorescent, count |
1 |
1.6 |
4.9 |
0.8 |
1.3 |
2.6 |
B- |
Reticulocyte medium fluorescent, count |
1 |
13.0 |
33.0 |
6.5 |
8.9 |
19.6 |
B- |
Reticulocyte, count |
1 |
11.0 |
29.0 |
5.5 |
7.8 |
16.8 |
P- |
Retinol |
1 |
6.2 |
21.0 |
3.1 |
5.5 |
10.6 |
S- |
Retinol |
2 |
13.6 |
19.0 |
6.8 |
5.8 |
17.1 |
S- |
Rheumatoid factor |
1 |
8.5 |
24.5 |
4.3 |
6.5 |
13.5 |
Back to top
<
|
Analyte |
Number of papers |
Biological Variation |
Desirable specification |
CVI |
CVg |
I(%) |
B(%) |
TE(%) |
S- |
SCC antigen |
1 |
39.4 |
35.7 |
19.7 |
13.3 |
45.8 |
P- |
S Protein |
1 |
5.8 |
63.4 |
2.9 |
15.9 |
20.7 |
P- |
Selenium |
1 |
12.0 |
14.0 |
6.0 |
4.6 |
14.5 |
B- |
Selenium |
1 |
12.0 |
12.0 |
6.0 |
4.2 |
14.1 |
P- |
Serine |
1 |
12.8 |
42.8 |
6.4 |
11.2 |
21.7 |
S- |
Sex hormone binding globulin (SHBG) |
2 |
13.05 |
36.35 |
6.53 |
9.66 |
20.42 |
(B)Erythr- |
Sodium |
1 |
1.8 |
12.4 |
0.9 |
3.1 |
4.6 |
(B)Leuc- |
Sodium |
1 |
51.0 |
36.4 |
25.5 |
15.7 |
57.7 |
S- |
Sodium |
21 |
0.6 |
0.7 |
0.3 |
0.23 |
0.73 |
B- |
Sodium Bicarbonate |
1 |
4.0 |
4.8 |
2.0 |
1.6 |
4.9 |
S- |
Sodium Bicarbonate |
7 |
4.8 |
4.7 |
2.4 |
1.7 |
5.6 |
Sweat- |
Sodium Chloride |
1 |
15.0 |
25.0 |
7.5 |
7.3 |
19.7 |
U- |
Sodium, output, 24 h. |
4 |
28.7 |
16.7 |
14.4 |
8.3 |
32.0 |
P- |
Soluble CD163 |
1 |
9.0 |
35.9 |
4.5 |
9.3 |
16.7 |
U- |
Specific gravity |
1 |
0.4 |
1.0 |
0.2 |
0.27 |
0.60 |
Semen- |
Spermatozoa, concentration |
1 |
26.8 |
56.4 |
13.4 |
15.6 |
37.7 |
Semen- |
Spermatozoa, morphology |
1 |
19.6 |
44.0 |
9.8 |
12.0 |
28.2 |
Semen- |
Spermatozoa, progressive motility |
1 |
15.2 |
32.8 |
7.6 |
9.0 |
21.6 |
Semen- |
Spermatozoa, fast progressive motility |
1 |
18.8 |
51.8 |
9.4 |
13.8 |
29.3 |
Semen- |
Spermatozoa, total motility |
1 |
18.4 |
29.8 |
9.2 |
8.8 |
23.9 |
Semen- |
Spermatozoa, vitality |
1 |
10.3 |
25.8 |
5.2 |
6.9 |
15.4 |
S- |
Superoxide dismutase |
1 |
17.1 |
10.5 |
8.6 |
5.0 |
19.1 |
(B)Erythr- |
Superoxide dismutase |
1 |
12.3 |
4.9 |
6.2 |
3.3 |
13.5 |
P- |
Taurine |
1 |
30.6 |
44.0 |
15.3 |
13.4 |
38.6 |
P- |
Testosterone |
1 |
12.6 |
40.80 |
6.3 |
10.68 |
21.07 |
S- |
Testosterone |
7 |
9.25 |
22.05 |
4.63 |
5.98 |
13.61 |
Saliva- |
Testosterone |
1 |
17.3 |
28.8 |
8.7 |
8.4 |
22.7 |
U- |
Testosterone |
1 |
25.0 |
--- |
12.5 |
--- |
--- |
S- |
Testosterone, free |
3 |
9.3 |
--- |
4.7 |
--- |
--- |
U- |
Testosterone, free |
1 |
51.7 |
--- |
25.9 |
--- |
--- |
S- |
Thyroglobulin |
2 |
14.0 |
39.0 |
7.0 |
10.4 |
21.9 |
S- |
Thyroglobulin antibody |
1 |
8.5 |
82.0 |
4.3 |
20.6 |
27.6 |
S- |
Thyroid peroxidase antibody |
1 |
11.3 |
147.0 |
5.7 |
36.9 |
46.2 |
P- |
Thyroid stimulating hormone (TSH) |
1 |
29.30 |
48.4 |
14.65 |
14.14 |
38.2 |
S- |
Thyroid stimulating hormone (TSH) |
9 |
19.3 |
24.6 |
9.7 |
7.8 |
23.7 |
S- |
Thyrotropin receptor antibody |
1 |
4.8 |
--- |
2.4 |
--- |
--- |
S- |
Thyroxine (T4) |
11 |
4.9 |
10.9 |
2.5 |
3.0 |
7.0 |
P- |
Thyroxine, free (FT4) |
1 |
7.1 |
9.1 |
3.55 |
2.89 |
8.74 |
S- |
Thyroxine, free (FT4) |
5 |
5.7 |
12.1 |
2.9 |
3.3 |
8.0 |
S- |
Thyroxine binding globulin (TBG) |
2 |
0.09 |
0.06 |
0.0 |
0.0 |
0.1 |
P- |
Tirosine |
1 |
10.5 |
61.0 |
5.3 |
15.5 |
24.1 |
S- |
Tissue polypeptide antigen (TPA) |
1 |
31.1 |
63.7 |
15.6 |
17.7 |
43.4 |
S- |
Tissue polypeptide specific antigen (TPS) |
1 |
36.1 |
108.0 |
18.1 |
28.5 |
58.3 |
U- |
Total catecolamines, concentration, 24h |
1 |
24.0 |
32.0 |
12.0 |
10.0 |
29.8 |
S- |
Transferrin |
5 |
3.0 |
4.3 |
1.5 |
1.3 |
3.8 |
P- |
Treonine |
1 |
17.9 |
33.1 |
9.0 |
9.4 |
24.2 |
S- |
Triglyceride |
31 |
19.9 |
32.7 |
9.95 |
9.57 |
25.99 |
P- |
Triiodothyronine (T3) |
1 |
9.4 |
18.5 |
4.7 |
5.19 |
12.94 |
S- |
Triiodothyronine (T3) |
10 |
6.9 |
12.3 |
3.45 |
3.53 |
9.22 |
S- |
Triiodothyronine, free (FT3) |
4 |
7.9 |
17.6 |
4.0 |
4.8 |
11.3 |
P- |
Troponin I |
1 |
37.1 |
179.2 |
18.55 |
45.75 |
76.36 |
S- |
Troponin I |
5 |
14.05 |
63.75 |
7.03 |
16.32 |
27.91 |
S- |
Troponin T |
1 |
30.5 |
90.0 |
15.3 |
23.7 |
48.9 |
P- |
Tryptophan |
1 |
22.7 |
152.6 |
11.4 |
38.6 |
57.3 |
S- |
Tumor Necrosis Factor-a (TNF-a)
|
1 |
43.0 |
29.0 |
21.5 |
13.0 |
48.4 |
S- |
Urate |
16 |
8.6 |
17.5 |
4.3 |
4.87 |
11.97 |
U- |
Urate, output, 24h |
2 |
16.8 |
14.4 |
8.4 |
5.53 |
19.39 |
S- |
Urea |
20 |
12.1 |
18.7 |
6.05 |
5.57 |
15.55 |
U- |
Urea, output, 24h |
4 |
17.4 |
25.4 |
8.7 |
7.7 |
22.1 |
P- |
Valine |
1 |
10.6 |
40.1 |
5.3 |
10.4 |
19.1 |
U- |
Vanilmandelic Acid concentration, 24h |
1 |
22.2 |
47.0 |
11.1 |
13.0 |
31.3 |
S- |
Vascular cell adhesion molecule-1 (VCAM-1) |
1 |
5.2 |
16.0 |
2.6 |
4.2 |
8.5 |
P- |
Vascular endotelial growth factor |
1 |
14.1 |
18.1 |
7.1 |
5.7 |
17.4 |
B- |
Vascular endotelial growth factor |
1 |
14.3 |
28.8 |
7.2 |
8.0 |
19.8 |
S- |
Vascular endotelial growth factor |
1 |
10.7 |
47.6 |
5.4 |
12.2 |
21.0 |
P- |
Vitamin B1 |
1 |
4.8 |
12.0 |
2.4 |
3.2 |
7.2 |
B- |
Vitamin B2 (Riboflavin) |
1 |
5.8 |
10.0 |
2.9 |
2.9 |
7.7 |
(B)Eryth- |
Vitamin B2 (Riboflavin) |
1 |
6.4 |
11.0 |
3.2 |
3.2 |
8.5 |
(B)Eryth- |
Vitamin B2 status (gluthation reductase activation) |
1 |
5.2 |
40.0 |
2.6 |
10.1 |
14.4 |
(B)Eryth- |
Vitamin B12 |
1 |
15.0 |
69.0 |
7.5 |
17.7 |
30.0 |
(B)Eryth- |
Vitamin B6 |
1 |
14.0 |
24.0 |
7.0 |
6.9 |
18.5 |
B- |
Vitamin B6 |
1 |
20.0 |
34.0 |
10.0 |
9.9 |
26.4 |
(B)Eryth- |
Vitamin E (Tocopherol) |
1 |
7.6 |
21.0 |
3.8 |
5.6 |
11.9 |
(B)Eryth- |
Vitamin K (Phylloquinone) |
1 |
38.0 |
44.0 |
19.0 |
14.5 |
45.9 |
S- |
VLDL Cholesterol |
2 |
27.6 |
--- |
13.8 |
--- |
--- |
P- |
Von Willebrand factor |
3 |
2.5 |
27.3 |
1.3 |
6.9 |
8.9 |
S- |
Water |
1 |
3.1 |
0.1 |
1.6 |
0.8 |
3.3 |
S- |
Zeaxanthine |
1 |
34.7 |
--- |
17.4 |
--- |
--- |
S- |
Zinc |
1 |
9.3 |
9.4 |
4.7 |
3.3 |
11.0 |
P- |
Zinc |
3 |
11.0 |
14.0 |
5.5 |
4.5 |
13.5 |
Back to top